Product
Vehicle solution
Aliases
Vehicle
3 clinical trials
3 indications
Indication
Androgenetic AlopeciaIndication
AlopeciaIndication
AndrogeneticClinical trial
International Phase III, Multi Center, Randomized, Double Blind, Placebo and Active Controlled and Parallel Group Clinical Trial to Evaluate the Efficacy and Safety of Oral Minoxidil 1 mg in Female Patients With Androgenetic AlopeciaStatus: Not yet recruiting, Estimated PCD: 2025-06-01
Clinical trial
A 6-month Phase 3, Multicenter, Prospective, Randomized, Double-Blind, Vehicle-Controlled Study, to Evaluate the Efficacy and Safety of Topically Applied Clascoterone Solution for the Treatment of Androgenetic Alopecia in Males, Followed by a 6-month Single-Blind Treatment With Clascoterone or Vehicle SolutionStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
A 6-month Phase 3, Multicenter, Prospective, Randomized, Double-Blind, Vehicle-Controlled Study, to Evaluate the Efficacy and Safety of Topically Applied Clascoterone Solution for the Treatment of Androgenetic Alopecia in Males, Followed by a 6-month Single-Blind Treatment With Clascoterone or Vehicle SolutionStatus: Recruiting, Estimated PCD: 2024-08-01